CC
FMI

Casdin Capital’s Foundation Medicine, Inc. FMI Stock Holding History

Casdin Capital’s Portfolio FMI Stock Details FMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-685,000
Closed -$93.6M – 41
2018
Q2 		$93.6M Buy
685,000
+165,000
+32% +$15M 13.1% 1
2018
Q1 		$41M Hold
520,000
– – 7.2% 2
2017
Q4 		$35.5M Buy
520,000
+40,000
+8% +$2.07M 8.64% 2
2017
Q3 		$19.3M Hold
480,000
– – 5.45% 7
2017
Q2 		$19.1M Hold
480,000
– – 7.06% 3
2017
Q1 		$15.5M Sell
480,000
-66,000
-12% -$1.65M 9.13% 2
2016
Q4 		$9.66M Buy
546,000
+131,000
+32% +$2.82M 7.98% 4
2016
Q3 		$9.69M Buy
415,000
+25,000
+6% +$568K 7.85% 3
2016
Q2 		$7.28M Buy
390,000
+55,000
+16% +$994K 7.24% 3
2016
Q1 		$6.09M Buy
335,000
+220,000
+191% +$3.54M 6.99% 3
2015
Q4 		$2.42M Buy
+115,000
New +$2.22M 2.14% 16

Casdin Capital's FMI Position: Q3 2018 in Review

Casdin Capital sold out of Foundation Medicine, Inc. (FMI) in Q3 2018, closing a stake of 685,000 shares — an estimated $93.6M sold.

Casdin Capital first reported a position in FMI in Q4 2015 and held it in 11 quarters. The position peaked at $93.6M in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • Casdin Capital reported no remaining Foundation Medicine, Inc. position as of Q3 2018 after selling out during the quarter.
  • Casdin Capital sold 685,000 Foundation Medicine, Inc. shares in Q3 2018, an estimated $93.6M.
  • Casdin Capital first reported a position in Foundation Medicine, Inc. in Q4 2015 and held it in 11 quarters.
  • Casdin Capital's Foundation Medicine, Inc. position peaked at $93.6M in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q3 2018.

Based on Casdin Capital's 13F filing for Q3 2018, filed 14 Nov 2018.